Salesforce.com shares have declined 17.7% over the past four weeks and 20.4% over the last 21 trading days, pushing several momentum indicators into oversold readings. The 14-day Relative Strength Index on the stock has fallen below 30, a level that has historically preceded short-term rebounds. Volume on down days has also outpaced up days by a 3:1 ratio, suggesting that much of the heavy selling pressure could be exhausted. Traders monitoring Bollinger Band readings note that the stock has touched the lower band three times in the past month, a pattern that has often marked near-term inflection points for high-beta technology names.

Wall Street analysts covering Salesforce.com have raised their fiscal year 2026 non-GAAP EPS forecasts by an average of 4.5% over the past six weeks. Of the 28 institutions providing guidance, 22 have increased estimates, with the median target now standing 6% above where it was at the start of January. Revenue projections have been revised upward by 2.8% on average, reflecting growing confidence in both subscription renewal rates—which held at 92% in the most recent quarter—and accelerated adoption of new modules. The consensus ‘buy’ ratio across the analyst community has climbed to 68%, the highest level since early 2025.

Salesforce’s Agentforce AI suite has seen customer deployments rise 45% year-over-year, yet the product line currently accounts for less than 5% of total revenue. Management’s guidance for AI-driven ARR growth remains cautious, projecting a 15% contribution by mid-2026. Meanwhile, operating margins expanded by 120 basis points in the last quarter as the company leveraged its scale to absorb development costs. Free cash flow improved to $1.8 billion, up 22% year-over-year, providing ample runway for continued R&D investment in Einstein AI and related automation tools.

Despite the recent share-price decline, Salesforce.com trades at 9.2 times forward free cash flow, a discount to its five-year average of 11.1 times. The company’s debt-to-EBITDA ratio stands at 1.9x, reflecting responsible leverage levels even after the integration of several large acquisitions, which contributed $28.7 billion in goodwill. Analysts argue that if consensus estimates hold, a return to the historical valuation multiple could imply upside of 25% from current levels. The board’s authorization of a new $5 billion share-repurchase program further underscores management’s confidence in intrinsic value and provides additional support for equity holders.